BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33848369)

  • 1. Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C.
    Pelland-Marcotte MC; Kulkarni K; Athale UH; Pole JD; Brandão LR; Sung L
    Am J Hematol; 2021 Jul; 96(7):796-804. PubMed ID: 33848369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from CYP-C.
    Pelland-Marcotte MC; Kulkarni K; Tran TH; Stammers D; Gupta S; Sung L; Athale UH
    Am J Hematol; 2024 Feb; 99(2):274-283. PubMed ID: 38164978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
    Tuckuviene R; Ranta S; Albertsen BK; Andersson NG; Bendtsen MD; Frisk T; Gunnes MW; Helgestad J; Heyman MM; Jonsson OG; Mäkipernaa A; Pruunsild K; Tedgård U; Trakymiene SS; Ruud E
    J Thromb Haemost; 2016 Mar; 14(3):485-94. PubMed ID: 26707629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of length of time to diagnosis and treatment on the survival of children with acute lymphoblastic leukemia: a population-based study.
    Baker JM; To T; Beyene J; Zagorski B; Greenberg ML; Sung L
    Leuk Res; 2014 Feb; 38(2):204-9. PubMed ID: 24333116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-C.
    Tibout P; Ledjiar O; Athale U; Rayar M; Kulkarni K; Truong T; Cellot S; Bittencourt H; Pelland-Marcotte MC; Tran TH
    Leuk Lymphoma; 2022 Dec; 63(13):3208-3216. PubMed ID: 36067507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia.
    Athale UH; Chan AK
    Thromb Res; 2003; 111(3):125-31. PubMed ID: 14678808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.
    Bhatia S; Sather HN; Heerema NA; Trigg ME; Gaynon PS; Robison LL
    Blood; 2002 Sep; 100(6):1957-64. PubMed ID: 12200352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of mediastinal mass in the formation of thrombi in pediatric patients with non-lymphoblastic lymphomas.
    Gartrell J; Kaste SC; Sandlund JT; Flerlage J; Zhou Y; Cheng C; Estepp J; Metzger ML
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28057. PubMed ID: 31736198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring disparities in event-free survival among children with acute lymphoblastic leukemia in an academic institute in Oklahoma, 2005-2019.
    Janitz AE; Barber R; Campbell JE; Xu C; Pokala HR; Blanchard J; McNall-Knapp RY
    Cancer Epidemiol; 2022 Dec; 81():102275. PubMed ID: 36215916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.
    Athale UH; Laverdiere C; Nayiager T; Delva YL; Foster G; Thabane L; Chan AK
    BMC Cancer; 2017 May; 17(1):313. PubMed ID: 28472942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
    Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.
    Athale UH; Flamand Y; Blonquist T; Stevenson KE; Spira M; Asselin BL; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29581. PubMed ID: 35316569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of childhood acute lymphoblastic leukemia treatment in a single center in Brazil: A survival analysis study.
    Bonilha TA; Obadia DDA; Valveson AC; Land MGP
    Cancer Rep (Hoboken); 2022 Jan; 5(1):e1452. PubMed ID: 34114751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central venous line dysfunction is an independent predictor of poor survival in children with cancer.
    Athale UH; Siciliano S; Cheng J; Thabane L; Chan AK
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):188-93. PubMed ID: 22278202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
    Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolism in children with cancer: a retrospective multicenter study in Korea.
    Choi HS; Kim HJ; Kang HJ; Lee JW; Shin HY; Park HJ; Park BK; Lee YH; Lee JA; Lim YJ; Park KD
    J Thromb Thrombolysis; 2019 May; 47(4):558-565. PubMed ID: 30666552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.